Navigation Links
Hundreds of alterations and potential drug targets to starve tumors identified
Date:4/22/2013

mote tumor formation as a result of efflux from mitochondria and accumulation of their substrates, fumarate and succinate. The researchers found that in colon cancer, accumulation of these metabolites may be caused by a significant decrease in the enzymes' expression. This was confirmed when metabolomics data from colon tumor patients showed significantly higher concentrations of fumarate in tumors than in normal tissue.

"These are just several examples of how cancer cells use various creative mechanisms to hijack the metabolism of native cells for their own purposes," said Dr. Vitkup.

For cancer researchers looking for new drug targets, Dr. Vitkup's team also found hundreds of differences between normal and cancer cells' use of isoenzymes. This opens up additional possibilities for turning off cancer's fuel and supply lines. Isoenzymes often catalyze the same reactions, but have different kinetic properties: Some act quickly and sustain rapid growth, while others are more sluggish. In kidney and liver cancers, for example, a quick-acting aldolase isoenzymesuitable for fast cell proliferationwas found to be more prevalent than the more typical slow-moving version found in normal kidney and liver tissue. Although a few examples of differential isoenzyme expression in tumors were already known, the Columbia researchers identified hundreds of isoenzymes with cancer-specific expression patterns.

"Inhibiting specific isoenzymes in tumors may be a way to selectively hit cancer cells without affecting normal cells, which could get by with other isoenzymes," said Dr. Hu.

In fact, a recent study from Matthew Vander Heiden's laboratory demonstrated the potential of targeting a specific isoenzyme, pyruvate kinase M2, expression of which often increases in tumors. "The comprehensive expression analysis suggests that a similar approach could potentially be applied in multiple other cases," said Dr. Vander Heiden.

Targeting metabolis
'/>"/>

Contact: Karin Eskenazi
ket2116@cumc.columbia.edu
212-342-0508
Columbia University Medical Center
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Hundreds of alterations and potential drug targets to starve cancer tumors identified
2. Medtronic Infuse Bone Graft Lawsuits: Bernstein Liebhard LLP Notes New Report Predicting Hundreds of Medtronic Infuse Lawsuits
3. High-throughput sequencing shows potentially hundreds of gene mutations related to autism
4. Physicians at Pain Care Bring Hope to Hundreds of Pain Management Patients Who Previously Had None Through Use of a New Procedure Called Spinal Cord Stimulation
5. Hundreds of random mutations in leukemia linked to aging, not cancer
6. Vanderbilt study finds diverse genetic alterations in triple-negative breast cancers
7. Molecular subtypes and genetic alterations may determine response to lung cancer therapy
8. Tekturna Infographic Released by d’Oliveira & Associates Imparts Potential Side Effects of Blood Pressure Drug
9. Key bone marrow protein identified as potential new leukemia treatment target
10. UCLA researchers find potential link between auto pollution, some childhood cancers
11. Flies model a potential sweet treatment for Parkinsons disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2014)... of Manchester have discovered why medication to treat asthma and ... Nature Medicine , show that drugs widely used to treat ... In the UK pneumonia, which is caused by an infection, ... more serious for babies, young children, the elderly, smokers and ... 5 million people in the UK are affected by asthma ...
(Date:7/27/2014)... Over the past five years, the ... thanks to many consumers valuing the taste and versatility ... Association of Canada's Canadian Coffee Drinking Study in 2011 ... per day. “This trend, coupled with many studies that ... tea on a daily basis, has stimulated consumer demand ...
(Date:7/27/2014)... The report, “Oil Filter & Fuel ... HCVs), Market Type (OE & Aftermarket), Filter Type (Oil ... - Industry Trends & Forecast to 2018”, defines and ... with analysis and forecasting of the global volume and ... to reach a revenue of $6.1 billion in 2018, ...
(Date:7/27/2014)... 1-Butene is a colorless, combustible gas with a ... be manufactured either through the separation from crude C4 ... alpha olefin (alkene) 1-Butene is a versatile chemical that ... chemicals such as linear light density polyethylene (LLDP), polybutene-1, ... market is extremely competitive. The market has several market ...
(Date:7/27/2014)... (PRWEB) July 27, 2014 Metachromatic ... a lysosomal storage disease which is commonly listed ... among the sphingolipidoses as it affects the metabolism ... of myelin, the fatty covering which acts as ... and peripheral nervous systems. MLD involves cerebroside sulfate ...
Breaking Medicine News(10 mins):Health News:Drugs used to treat lung disease work with the body clock 2Health News:Coffee and Tea Production in Canada Industry Market Research Report Now Available from IBISWorld 2Health News:Coffee and Tea Production in Canada Industry Market Research Report Now Available from IBISWorld 3Health News:Oil Filter & Fuel Filter Market Worth $18.6 Billion by 2018 - Report by MarketsandMarkets 2Health News:Oil Filter & Fuel Filter Market Worth $18.6 Billion by 2018 - Report by MarketsandMarkets 3Health News:Oil Filter & Fuel Filter Market Worth $18.6 Billion by 2018 - Report by MarketsandMarkets 4Health News:Oil Filter & Fuel Filter Market Worth $18.6 Billion by 2018 - Report by MarketsandMarkets 5Health News:North America 1-Butene Market is Expected to Reach $794 million in 2018 - New Report by MicroMarket Monitor 2Health News:North America 1-Butene Market is Expected to Reach $794 million in 2018 - New Report by MicroMarket Monitor 3Health News:North America 1-Butene Market is Expected to Reach $794 million in 2018 - New Report by MicroMarket Monitor 4Health News:Metachromatic Leukodystrophy Therapeutics Clinical Trials Market Review H2 2014 Report Available at LifeScienceIndustryResearch.com 2Health News:Metachromatic Leukodystrophy Therapeutics Clinical Trials Market Review H2 2014 Report Available at LifeScienceIndustryResearch.com 3Health News:Metachromatic Leukodystrophy Therapeutics Clinical Trials Market Review H2 2014 Report Available at LifeScienceIndustryResearch.com 4Health News:Metachromatic Leukodystrophy Therapeutics Clinical Trials Market Review H2 2014 Report Available at LifeScienceIndustryResearch.com 5
... , MONDAY, Aug. 1 (HealthDay News) -- ... mental health disorders are at increased risk for chronic ... study. Researchers examined data from people in 10 ... Health Surveys initiative. The team looked at anxiety disorders ...
... mothers experienced psychological trauma during their pregnancies show signs ... The researchers discovered that this prenatal exposure to stress ... aging processes. The study results, which appear online this ... of Sciences , point to the importance of maternal ...
... (August 1, 2011) Two new studies published in ... Medicine (JNM) provide insight into the potential of ... dementia and to identify pharmaceuticals to slow the progress ... and the Alzheimer,s Association guidelines for detecting Alzheimer,s-related brain ...
... (HealthDay News) -- Despite the popularity of colon cleansing, ... done at home or in day spas -- offers any ... can cause serious side effects ranging from vomiting to kidney ... Colon cleansing -- also called colonic irrigation or colonic hydrotherapy ...
... leukemia chemotherapy drug may help breast cancer patients ... the widely-used drug, new research from the ... Interestingly, researchers found that taxoxifen combined with dasatinib, ... by cancer-associated fibroblasts in the surrounding tissue by ...
... July 31 (HealthDay News) -- A gene variant associated ... a team of researchers working together in a new ... gene variant was not present in European Americans and ... be identified in black Americans. The researchers, analysis ...
Cached Medicine News:Health News:Childhood Depression, Anxiety Tied to Pain in Adulthood 2Health News:UCI-led study links prenatal exposure to stress with accelerated cell aging 2Health News:New JNM research supports upcoming Alzheimer's disease guidelines 2Health News:Colon Cleansing Has No Health Benefit, May Harm: Report 2Health News:Leukemia drug reverses tamoxifen-resistance in breast cancer cells 2
(Date:7/24/2014)... PARK, Kan. , July 24, 2014 /PRNewswire/ ... of two compounds that will be added to ... with Australian-based CIMTECH Pty Ltd, a biotechnology company. ... PAR 122 have shown promise in bone regeneration ... license to develop the compounds for the veterinary ...
(Date:7/24/2014)... , Deutschland, und MARSEILLE ... -- , Weltweite ... ermöglicht QIAGEN die Entwicklung von Tests ... für Blutkrebs  Neuer Test weist ... mit Knochenmarkserkrankungen (myelodysplastischen Syndromen) einen günstigen Krankheitsverlauf ...
(Date:7/24/2014)... Calif., July 24, 2014  Abaxis, Inc. (NasdaqGS: ... blood analysis systems, today reported financial results for the ... First quarter overview: , Revenues of $47.5 million, ... Diluted EPS of $0.21, up 50% over last year,s ... market revenues of $7.2 million, up 20% over last ...
Breaking Medicine Technology:Parnell Acquires License for Intellectual Property and Rights to Develop Compounds for Bone and Dermal Regeneration 2Parnell Acquires License for Intellectual Property and Rights to Develop Compounds for Bone and Dermal Regeneration 3Parnell Acquires License for Intellectual Property and Rights to Develop Compounds for Bone and Dermal Regeneration 4QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 2QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 3QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 4QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 5Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 2Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 3Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 4Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 5Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 6Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 7Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 8Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 9Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 10Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 11
... (NYSE: LMT ) has completed its acquisition of ... is the largest provider of outsourced medical evaluation services to ... 450,000 evaluations last year. Founded in 1981, ... to the Department of Defense, the VA and other U.S. ...
... BRUNSWICK, N.J., Sept. 27, 2011 Bluestar Silicones Senior ... to Control Bacterial Growth" at the upcoming Medical Silicones ... Dr. Hoy, the rising number of hospital acquired infections, ... are factors that contribute to growing demand for medical ...
Cached Medicine Technology:Bluestar Silicones to Present Antimicrobial Silicones at Medical Silicones Conference in Boston 2
The Vitek 2 - XL is a fully automated bacteriology system that performs bacterial identification and susceptibility testing analysis using a standard inoculum. It detects resistance and helps combat ...
IDS Rapid ANA II System, a microbial identification system....
IDS Rapid STR, a microbial identification system....
IDS Rapid One, a microbial identification system....
Medicine Products: